Menu
Recruiting NCT07458334

Skincare Benefits of Kaempferol-Containing Masks

No phase Interventional Skin Biophysical Properties

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Kaempferol-containing facial mask, Hyaluronic acid-containing facial mask.
Who it may be relevant to
Registry conditions: Skin Biophysical Properties. Basic parameters: 25 years — 60 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Clinical Evaluation of the Skincare Benefits of Kaempferol-Containing Masks

Overview

This is an open-label, two-arm study, which will evaluate the effects of Kaempferol-containing masks on skin biophysical properties

Interventions

  • Other Kaempferol-containing facial mask
    Kaempferol-containing facial mask
  • Other Hyaluronic acid-containing facial mask
    Hyaluronic acid-containing facial mask

Primary outcome measures

  • Skin hydration [Time frame: 12 weeks]
  • Skin transepidermal water loss [Time frame: 12 weeks]
  • Skin coloration [Time frame: 12 weeks]
  • Skin elasticity [Time frame: 12 weeks]
  • Skin wrinkles [Time frame: 12 weeks]
  • Skin pores [Time frame: 12 weeks]

Eligibility criteria

Inclusion criteria

  • Female subjects between 25 and 60 years old

Exclusion criteria

  • Pregnant or breastfeeding women
  • Subjects who are allergic to the product
  • Subjects with psoriasis or atopic dermatitis
  • Subjects who have taken systemic corticosteroids within 2 weeks
  • Subjects who have taken oral retinoid within 1 week
  • Subjects with severe medical conditions, such as cardiovascular, liver, kidney, or hematopoietic system disorders
  • Subjects with tuberculosis
  • Subjects with viral hepatitis or other infectious diseases
  • Subjects with psychiatric disorders
  • Subjects with external trauma or infections

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Taiwan · 1 center
  • Kaohsiung Medical University Chung-Ho Memorial Hospital — Kaohsiung City

Identifiers

NCT: NCT07458334 · S-113-20

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗